These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21575919)

  • 1. Trandolapril, but not verapamil nor their association, restores the physiological renal hemodynamic response to adrenergic activation in essential hypertension.
    Lambertucci L; Di Serio C; Castellani S; Torrini M; Lotti E; Cristofari C; Masotti G; Marchionni N; Ungar A
    Transl Res; 2011 Jun; 157(6):348-56. PubMed ID: 21575919
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of light exercise on renal hemodynamics in patients with hypertension and chronic renal disease.
    Svarstad E; Myking O; Ofstad J; Iversen BM
    Scand J Urol Nephrol; 2002; 36(6):464-72. PubMed ID: 12623513
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Renal hemodynamics and proteinuria in chronic glomerulonephritis treated with beta-receptor blockers or ace inhibitors].
    Erley CM; Berger ED; Heyne N; Klass M; Krämer D; Braun N; Wolf S; Risler T
    Dtsch Med Wochenschr; 1997 Aug; 122(31-32):953-8. PubMed ID: 9280714
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Renal adaptive mechanisms in aged and hypertensive humans: possible effects of treatment.
    Di Serio C; Cristofari C; Torrini M; Cantini C; Lambertucci L; Castellani S; Masotti G; Ungar A
    Med Sci Monit; 2001; 7(6):1203-11. PubMed ID: 11687731
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Renal hemodynamics in hypertensive renal allograft recipients: effects of calcium antagonists and ACE inhibitors.
    Grekas D; Dioudis C; Kalevrosoglou I; Alivanis P; Derveniotis V; Tourkantonis A
    Kidney Int Suppl; 1996 Jun; 55():S97-100. PubMed ID: 8743523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized and double-blind comparison of isradipine and spirapril as monotherapy and in combination on the decline in renal function in patients with chronic renal failure and hypertension.
    Petersen LJ; Petersen JR; Talleruphuus U; Møller ML; Ladefoged SD; Mehlsen J; Jensen HA
    Clin Nephrol; 2001 May; 55(5):375-83. PubMed ID: 11393383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The TEAM study--a study of the effectiveness and tolerance of treatment of essential hypertension with a fixed combination of trandolapril and verapamil].
    Widimský J; Dzúrik R
    Vnitr Lek; 1998 Jun; 44(6):326-31. PubMed ID: 9820054
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of trandolapril alone or in combination with a calcium channel blocker in hypertensive patients over 60 years of age].
    Gosse P; Vaur L; Dutrey-Dupagne C; Genes N; Destrée D; Elkik F
    Ann Cardiol Angeiol (Paris); 1995 Nov; 44(9):517-24. PubMed ID: 8745662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 26-week, prospective, open-label, uncontrolled, multicenter study to evaluate the effect of an escalating-dose regimen of trandolapril on change in blood pressure in treatment-naive and concurrently treated adult hypertensive subjects (TRAIL).
    Tytus RH; Burgess ED; Assouline L; Vanjaka A
    Clin Ther; 2007 Feb; 29(2):305-15. PubMed ID: 17472822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal outcomes in high-risk hypertensive patients treated with an angiotensin-converting enzyme inhibitor or a calcium channel blocker vs a diuretic: a report from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
    Rahman M; Pressel S; Davis BR; Nwachuku C; Wright JT; Whelton PK; Barzilay J; Batuman V; Eckfeldt JH; Farber M; Henriquez M; Kopyt N; Louis GT; Saklayen M; Stanford C; Walworth C; Ward H; Wiegmann T
    Arch Intern Med; 2005 Apr; 165(8):936-46. PubMed ID: 15851647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Subpressor doses of angiotensin II do not increase albumin excretion in humans.
    Erley CM; Grau C; Furian TC; Wolf S; Braun N; Risler T
    Clin Nephrol; 1996 Nov; 46(5):312-8. PubMed ID: 8953120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of glomerular filtration in essential hypertension: role of abnormal Na+ transport and atrial natriuretic peptide.
    Semplicini A; Ceolotto G; Sartori M; Maresca A; Baritono E; De Toni R; Paparella I; Calò L
    J Nephrol; 2002; 15(5):489-96. PubMed ID: 12455714
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antihypertensive properties of a high-dose combination of trandolapril and verapamil-SR.
    Messerli F; Frishman WH; Elliott WJ; Bacher PH; Pepine CJ
    Blood Press Suppl; 2007 Mar; 1():6-9. PubMed ID: 17566313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PGl2 analogue mitigates the progression rate of renal dysfunction improving renal blood flow without glomerular hyperfiltration in patients with chronic renal insufficiency.
    Fujita T; Fuke Y; Satomura A; Hidaka M; Ohsawa I; Endo M; Komatsu K; Ohi H
    Prostaglandins Leukot Essent Fatty Acids; 2001 Oct; 65(4):223-7. PubMed ID: 11728176
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of trandolapril and its fixed-dose combination with verapamil on circulating adhesion molecules levels in hypertensive patients with type 2 diabetes.
    Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodriguez-Lopez L; Escalante-Acosta BA
    Clin Exp Hypertens; 2008 Oct; 30(7):682-8. PubMed ID: 18855271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal protection in essential hypertension: how do angiotensin-converting enzyme inhibitors compare with calcium antagonists?
    Bauer JH; Reams GP
    J Am Soc Nephrol; 1990 Nov; 1(5 Suppl 2):S80-7. PubMed ID: 16989071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal effects of calcium blockade by tiapamil in normal and hypertensive subjects.
    Ribstein J; Cristol JP; Elkik F; Mimran A
    J Hypertens Suppl; 1985 Dec; 3(3):S165-7. PubMed ID: 2856696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of intensified blood-pressure reduction on renal function and albumin excretion in primary hypertension. Addition of felodipine or ramipril to long-term treatment with beta-blockade.
    Siewert-Delle A; Ljungman S; Hartford M; Wikstrand J
    Am J Hypertens; 1995 Feb; 8(2):113-23. PubMed ID: 7755939
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nephroprotection by antihypertensive agents.
    Schmieder RE
    J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S55-64. PubMed ID: 7898095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of trandolapril therapy and its combination with a calcium channel blocker on plasma adiponectin levels in patients with type 2 diabetes and hypertension.
    Rubio-Guerra AF; Vargas-Robles H; Vargas-Ayala G; Rodríguez-Lopez L; Castro-Serna D; Escalante-Acosta BA
    Ther Adv Cardiovasc Dis; 2011 Aug; 5(4):193-7. PubMed ID: 21737486
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.